The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.07) by 157.14 percent. The company reported quarterly sales of $99.901 million which missed the analyst consensus estimate of $107.542 million by 7.11 percent. This is a 21.78 percent increase over sales of $82.035 million the same period last year.